Improper analysis of trials randomised using stratified blocks or minimisation

Statistics in Medicine

Volumn 31, Issue 4, 2012, Pages 328-340

  Kahan, Brennan C ^a   Morris, Tim P ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

Adjustment; Clinical trials; Covariates; Minimisation; Stratification; Unadjusted analysis

Indexed keywords

ALPHA INTERFERON; DEOXYRIBONUCLEASE; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BREAST CANCER; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; DECOMPRESSION SURGERY; HUMAN; INFORMATION PROCESSING; INTERVERTEBRAL DISK HERNIA; INTERVERTEBRAL DISKECTOMY; KIDNEY CARCINOMA; MATHEMATICAL ANALYSIS; MEDICAL LITERATURE; OSWESTRY DISABILITY INDEX; OUTCOME ASSESSMENT; PLEURA EFFUSION; RANDOMIZATION; SIMULATION; STATISTICS; STRATIFIED SAMPLE; VERTEBRAL CANAL STENOSIS;

ANTINEOPLASTIC AGENTS; BACK INJURIES; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CARCINOMA; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DEOXYRIBONUCLEASES; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; LIVER CIRRHOSIS, BILIARY; MALE; MEDROXYPROGESTERONE ACETATE; PENICILLAMINE; PLEURAL EFFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TAMOXIFEN; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84855936105     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4431     Document Type: Article

References (43)

1. Lachin JM. Properties of simple randomization in clinical trials. Controlled Clinical Trials 1988 9: 312-326, DOI: 10.1016/0197-2456(88)90046-3.
2. Kalish LA, Begg CB. Treatment allocation methods in clinical trials: a review. Statistics in Medicine 1985 4: 129-144, DOI: 10.1002/sim.4780040204.
3. Fisher RA. The arrangement of field experiments. Journal of the Ministry of Agriculture of Great Britain 1926 33: 83-94.
4. Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971 58(3): 403-417, DOI: 10.1093/biomet/58.3.403.
5. Wei LJ, Lachin JM. Properties of urn randomisation in clinical trials. Controlled Clinical Trials 1994 9: 345-364, DOI: 10.1016/0197-2456(88)90048-7.
6. Atkinson AC. Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrika 1982 69(1): 61-67, DOI: 10.1093/biomet/69.1.61.
7. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975 31: 103-115.
8. Pond GR, Tang PA, Welch SA, Chen EX. Trends in the application of dynamic allocation methods in multi-arm cancer clinical trials. Clinical Trials 2010 7: 227-234, DOI: 10.1177/1740774510368301.
9. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials a review. Controlled Clinical Trials 2002 23(6): 662-674, DOI: 10.1016/S0197-2456(02)00242-8.
10. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. The Lancet 2002 359(9310): 966-970, DOI:10.1016/S0140-6736(02)08029-7.
11. Committee for Proprietary Medicinal Products. Points to consider on adjustment for baseline covariates. Statistics in Medicine 2004 23: 701-709, DOI:10.1002/sim.1647.
12. ICH E9 Expert Working Group. Statistical principles for clinical trials: ICH harmonised tripartite guideline. Statistics in Medicine 1999 18: 1905-1942, DOI:10.1002/(SICI)1097-0258(19990815)18:15%3C1903::AID-SIM188%3E3.0.CO;2-F.
13. Raab GM, Day S, Sales J. How to select covariates to include in the analysis of a clinical trial. Controlled Clinical Trials 2000 21: 330-342, DOI: 10.1016/S0197-2456(00)00061-1.
14. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. Journal of Clinical Epidemiology 1999 52: 19-26, DOI: 10.1016/S0895-4356(98)00138-3.
15. Senn S. Statistical Issues in Drug Development, Wiley:Chichester, 2007.
16. Redmond C, Colton T. Biostatistics in Clinical Trials, Wiley:Chichester, 2001.
17. Piantadosi S. Clinical Trials: A Methodologic Perspective, Wiley:New Jersey, 2005.
18. Lachin JM, Matts JP, Wei LJ. Randomization in clinical trials: conclusions and recommendations. Controlled Clinical Trials 1988 9: 365-374, DOI:10.1016/0197-2456(88)90049-9.
19. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statistics in Medicine 2002 21: 2917-2930, DOI:10.1002/sim.1296.
20. Wang D, Bakhai A. Clinical Trials: A Practical Guide to Design, Analysis, and Reporting, Remedica:London, 2006.
21. Girling D, Parmar M, Stenning S, Stephens R, Stewart L. Clinical Trials in Cancer: Principles and Practice, Oxford University Press:Oxford, 2003.
22. Pocock SJ. Clinical Trials: A Practical Approach, Wiley:Chichester, 1983.
23. Altman DG. Practical Statistics for Medical Research, Chapman and Hall:London, 1991.
24. Meinert CL. Clinical Trials: Design, Conduct, and Analysis, Oxford University Press:Oxford, 1986.
25. Altman DG, Bland JM. Treatment allocation by minimisation. BMJ 2005 330(7495): 843+, DOI: 10.1136/bmj.330.7495.843.
26. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002 359: 515-519, DOI: 10.1016/S0140-6736(02)07683-3.
27. Rovers MM, Straatman H, Zielhuis GA. Comparison of balanced and random allocation in clinical trials: a simulation study. European Journal of Epidemiology 2000 16: 1123-1129, DOI: 10.1023/A:1010907912024.
28. Weir CJ, Lees KR. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Statistics in Medicine 2003 22: 705-726, DOI:10.1002/sim.1366.
29. Forsyth AB. Validity and power of tests when groups have been balanced for prognostic factors. Computational Statistics and Data Analysis 1987 5: 193-200, DOI: 10.1016/0167-9473(87)90015-6.
30. Hagino A, Hamada C, Yoshimura I, Ohashi Y, Sakamoto J, Nakazato H. Statistical comparison of random allocation methods in cancer clinical trials. Controlled Clinical Trials 2004 25: 572-584.
31. Birkett NJ. Adaptive allocation in randomized controlled trials. Controlled Clinical Trials 1985 6: 146-155, DOI: 10.1016/0197-2456(85)90120-5.
32. Parzen M, Lipsitz SR, Dear KBG. Does clustering affect the usual test statistics of no treatment effect in a randomized clinical trial?Biometrical Journal 1998 40(4): 385-402, DOI:10.1002/(SICI)1521-4036(199808)40:4%3C385::AID-BIMJ385%3E3.0.CO;2-%23.
33. Hauck WW, Anderson S, Marcus SM. Should we adjust for covariates in nonlinear regression analyses of randomized trials?Controlled Clinical Trials 1998 19: 249-256, DOI: 10.1016/S0197-2456(97)00147-5.
34. Robinson LD, Jewell NP. Some surprising results about covariate adjustment in logistic regression models. International Statistical Review 1991 58: 227-240.
35. McGregor AH, Doré CJ, Morris TP, Morris S, Jamrozik K. Function after spinal treatment, exercise and rehabilitation (FASTER): improving the functional outcome of spinal surgery. BMC Musculoskeletal Disorders 2010 11(1): 17+, DOI: 10.1186/1471-2474-11-17.
36. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CWH, Ali N, Kinnear Wet al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. New England Journal of Medicine 2011 365(6): 518-526, DOI: 10.1056/NEJMoa1012740.
37. Royston P, Sauerbrei W. Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables, Wiley:Chichester, 2008.
38. Bender R, Augustin T, Blettner M. Generating survival times to simulate Cox proportional hazards models. Statistics in Medicine 2005 24, DOI:10.1002/sim.2059.
39. Collett D. Modelling Survival Data in Medical Research, Chapman and Hall:London, 1994.
40. Moher D, Hopewell D, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. British Medical Journal 2010 240, DOI: 10.1136/bmj.c869.
41. Pocock SJ. Clinical Trials: A Practical Approach, Wiley:Chichester, 1983.
42. Freeman PR. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Statistics in Medicine 1989 8(12): 1421-1432, DOI:10.1002/sim.4780081202.
43. Matts JP, Lachin JM. Properties of permuted-block randomization in clinical trials. Controlled Clinical Trials 1988 9(4): 327-344, DOI: 10.1016/0197-2456(88)90047-5.